Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Starting your retirement plan at the right age can make all the difference. Explore the benefits of early retirement planning.
26,459 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Rocket Lab reports record backlog and margin gains, while Intuitive Machines pursues a transformative acquisition to ...
Capitol Hill politics put crypto regulation on a slower track, as a Senate leader signals the Clarity Act may not rea...
A Trump-themed meme coin surged as promoters advertised a Mar-a-Lago gala, with White House attendance unconfirmed an...
The United States announced two Section 301 investigations spanning 60 economies, prompting swift Asian responses and...
A fresh, per-capita violence ranking shifts attention away from familiar conflict zones, signaling new risk dynamics ...
The VIX eased toward the mid-20s as equities edged higher and oil spiked on geopolitical tensions. Analysts say the m...
A newer NEOS-led family of covered call ETFs is drawing attention for stronger NAV resilience and higher income poten...
A March 17, 2026 report from Muddy Waters Research targets SoFi Technologies, spurring volatility as KBW weighs in. S...
The Federal Reserve held rates steady this week, but uncertainty remains. Three principal concerns are rattling inves...
Grayscale filed with the SEC to launch the HYPE ETF, which would trade on Nasdaq under GHYP if approved. The fund wou...
U.S. prosecutors allege a scheme to move Nvidia GPUs and servers to China, with Supermicro’s co-founders at the cente...